Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-01-24 09:46 am Purchase | 2023-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | BlackRock Inc. BLK | 6,351,750 10.700% | 86,745![]() (+1.38%) | Filing History |
2024-01-23 09:04 am Sale | 2023-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | STATE STREET CORP STT | 2,206,018 3.730% | -974,680![]() (-30.64%) | Filing History |
2023-09-07 10:14 am Sale | 2023-08-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | FEDERATED HERMES INC. FHI | 2,341,335 4.110% | -3,963,147![]() (-62.86%) | Filing History |
2023-07-07 4:35 pm Purchase | 2023-06-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | BlackRock Inc. BLK | 6,265,005 11.000% | 2,541,291![]() (+68.25%) | Filing History |
2023-03-28 6:51 pm Purchase | 2023-03-02 | 13D | Rhythm Pharmaceuticals, Inc. RYTM | New Enterprise Associates 13, L.P. | 92,909,956 5.100% | 88,000,000![]() (+1792.28%) | Filing History |
2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | RA Capital Management, L.P. | 5,516,067 9.800% | 645,000![]() (+13.24%) | Filing History |
2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | BAKER BROS. ADVISORS LP | 6,354,608 11.300% | 291,906![]() (+4.81%) | Filing History |
2023-02-09 4:01 pm Purchase | 2022-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | PRIMECAP MANAGEMENT CO/CA/ | 6,911,142 12.270% | 654,151![]() (+10.45%) | Filing History |
2023-02-09 12:01 pm Sale | 2022-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | JANUS HENDERSON GROUP PLC JHG | 1,240,153 2.200% | -1,893,782![]() (-60.43%) | Filing History |
2023-02-07 6:12 pm Purchase | 2022-12-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | GOLDMAN SACHS GROUP INC GS | 5,201,260 9.200% | 2,143,701![]() (+70.11%) | Filing History |
2023-02-03 4:16 pm Purchase | 2022-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | STATE STREET CORP STT | 3,180,698 5.640% | 3,180,698![]() (New Position) | Filing History |
2023-02-03 12:09 pm Purchase | 2022-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | BlackRock Inc. BLK | 3,723,714 6.600% | 2,546,139![]() (+216.22%) | Filing History |
2023-02-01 11:57 am Purchase | 2022-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | FEDERATED HERMES INC. FHI | 6,304,482 11.190% | 1,239,369![]() (+24.47%) | Filing History |
2022-10-07 4:20 pm Purchase | 2022-09-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | BAKER BROS. ADVISORS LP | 6,062,702 10.900% | 2,199,463![]() (+56.93%) | Filing History |
2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | BlackRock Inc. BLK | 1,177,575 2.300% | -2,150,486![]() (-64.62%) | Filing History |
2022-04-11 11:14 am Purchase | 2022-03-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | FEDERATED HERMES INC. FHI | 5,065,113 10.060% | 2,261,778![]() (+80.68%) | Filing History |
2022-02-14 4:17 pm Purchase | 2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | BAKER BROS. ADVISORS LP | 3,863,239 7.700% | 1,548,366![]() (+66.89%) | Filing History |
2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | RA Capital Management, L.P. | 4,871,067 9.700% | 692,000![]() (+16.56%) | Filing History |
2022-02-14 2:53 pm Purchase | 2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | FEDERATED HERMES INC. FHI | 2,803,335 5.580% | 1,027,631![]() (+57.87%) | Filing History |
2022-02-11 4:17 pm Sale | 2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | James E. Flynn | 1,867,467 3.710% | -853,736![]() (-31.37%) | Filing History |